Sign in
CompletedNo phase

Clinical Investigation of a Small Aperture Extended Depth of Focus Intraocular Lens in Patients With Complex Corneas

Key facts

Who runs it
AcuFocus, Inc.
Where
Philippines and Singapore2 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
45 people enrolled
Started
12 Jul 2022
Ended
28 Nov 2024
Type of study
Interventional
Treatments tested
  • IC-8 Intraocular Lens (IOL)
Record updated
19 December 2024

Who can take part

Age
22 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 21 criteriaShow less

Who can take part

  • Minimum 22 years of age
  • Able to comprehend and have signed a statement of informed consent
  • Availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visit(s)
  • Planned crystalline lens removal by phacoemulsification, with or without femtosecond laser-assisted extraction, and posterior chamber IOL implantation
  • Planned cataract removal or planned clear lens exchange in both eyes
  • Potential for postoperative best-corrected distance visual acuity (BCDVA) of 20/32 or better after crystalline lens removal
  • Having complex corneas with irregular astigmatism
  • Having clear central cornea
  • Having best-corrected distance visual acuity (BCDVA) or 20/40 or worse in either eye with or without a glare source (patients with bilateral cataract)

Who cannot take part

  • Previous ocular surgery as specified by the protocol
  • Use of systemic or ocular medications as specified by the protocol
  • Concurrent participation or participation in any clinical investigation up to 30 days prior to preoperative visit
  • Presence of ocular abnormalities or conditions (other than corneal irregularities) as specified by the protocol
  • Conditions requiring planned ocular surgical intervention
  • Severe dry eye or other conditions (such as hormonal fluctuations) that could lead to unstable refraction and/or visual acuity measurements or eye discomfort even with ocular lubricants or dry eye medication
  • Requiring an IC-8 IOL outside the available spherical power range
  • Pharmacologically dilated pupil size less than 6 mm in either eye
  • Preoperative corneal astigmatism >1.50 diopters in the eye to be implanted with the IC-8 IOL
  • Active or recurrent anterior segment pathology
  • Congenital bilateral cataracts
  • Patient is pregnant or nursing

This trial has no sites in United States.

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The objective of this study is to evaluate the clinical outcomes of the IC-8 IOL implanted in patients with complex corneas after crystalline lens removal.

The group in the trial

  • IC-8 IOL GroupTreatment being tested

    A monofocal or monofocal toric IOL implanted in the first eye of a subject and the IC-8 IOL implanted in the second eye.

    Treatment: IC-8 Intraocular Lens (IOL)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
19 December 2024